CRB3 and neoplasm: We speculated that CRB3 regulated TAZ through AMOT/p130, and our results suggest that TAZ/β-catenin was the key downstream targets of CRB3, whose activities sustained the self-renewal and tumor-initiation capacities of breast CSCs.